Forte Biosciences (FBRX) Assets Average (2017 - 2026)

Forte Biosciences (FBRX) has 10 years of Assets Average data on file, last reported at $75.0 million in Q1 2026.

• Assets Average for Q1 2026 came in at $75.0 million, up 37.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.0 million (up 37.59% YoY), and the FY2025 annual result was $72.2 million, up 43.56% from the prior year.
• Assets Average slipped to $75.0 million in Q1 2026 per FBRX's latest filing, from $89.9 million in the prior quarter.
• Over five years, Assets Average peaked at $102.4 million in Q3 2025 and troughed at $22.0 million in Q3 2024.
• A 5-year average of $50.1 million and a median of $42.3 million in 2022 frame the typical range for Assets Average.
• The sharpest annual moves came in 2024 and 2025: Assets Average slumped 44.32% in 2024, then soared 365.36% in 2025.
• A 5-year view of Assets Average shows it stood at $43.6 million in 2022, then retreated by 0.31% to $43.4 million in 2023, then decreased by 8.46% to $39.8 million in 2024, then surged by 126.23% to $89.9 million in 2025, then fell by 16.6% to $75.0 million in 2026.
• Business Quant data shows FBRX's Assets Average at $75.0 million in Q1 2026, $89.9 million in Q4 2025, and $102.4 million in Q3 2025.